Prepare to have your mind expanded by Dr. Michael Koren's insights straight from the American College of Cardiology meeting in Atlanta, where he’s sparking excitement with new research on heart health and cholesterol management. As Dr. Koren talks about the new drug Inclisiran that's revolutionizing cholesterol treatment with its vaccine-like qualities, you’ll understand why this biannual injection could be a game-changer in the fight against heart disease.

This episode isn't just about groundbreaking treatments; it's an eye-opener to the power of clinical research and how it propels medical advancements. Dr. Koren intricately explains how participation in clinical trials with organizations like ENCORE Research Center is critical—and can lead to substantial global health improvements.  Join us for a session that isn't merely informative but could also be the impetus for you to contribute to a healthier future.

Recording Date: April 8, 2024

Comparison of an “Inclisiran First” Strategy With Usual Care in Patients With Atherosclerotic Cardiovascular Disease - VICTORION-INITIATE

Inclisiran First Strategy Safe, Effective for LDL-C Control in ASCVD Patients

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!